We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$11.2M
2
XOM icon
ExxonMobil
XOM
+$10.8M
3
AAPL icon
Apple
AAPL
+$10.8M
4
IBB icon
iShares Biotechnology ETF
IBB
+$10.2M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.12M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$265M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$98.3M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$32.7M
4
VNQ icon
Vanguard Real Estate ETF
VNQ
+$18.2M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$14.9M

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MBAI
3851
Check-Cap
MBAI
$10.9M
– –
-2
Closed -$1K
CHMG icon
3852
Chemung Financial Corp
CHMG
$392M
– –
-62
Closed -$2K
CHN
3853
DELISTED
China Fund
CHN
– –
-1,289
Closed -$21K
CHNR icon
3854
China Natural Resources
CHNR
$5.15M
– –
-20
Closed -$1K
CHRS icon
3855
Coherus Oncology
CHRS
$196M
– –
-76
Closed -$2K
CHY
3856
Calamos Convertible and High Income Fund
CHY
$1.06B
$0 ﹤0.01%
+27
New +$285
CIG.C icon
3857
CEMIG Ordinary Shares
CIG.C
$8.95B
$0 ﹤0.01%
37
-975
-96% -$1.48K
CIL
3858
DELISTED
VictoryShares International Volatility Wtd ETF
CIL
– –
-296
Closed -$10K
CIVI
3859
DELISTED
Civitas Resources
CIVI
– –
-1
Closed –
CIVB icon
3860
Civista Bancshares
CIVB
$589M
– –
-66
Closed -$1K
CIX icon
3861
Comp X International
CIX
$371M
– –
-7
Closed –
CLLS
3862
Cellectis
CLLS
$285M
– –
-200
Closed -$5K
CLM icon
3863
Cornerstone Strategic Value Fund
CLM
$2.25B
– –
-671
Closed -$10K
CLMB icon
3864
Climb Global Solutions
CLMB
$519M
– –
-56
Closed –
CLRB icon
3865
Cellectar Biosciences
CLRB
$20.5M
– –
0
– -$2K
CLWT icon
3866
Euro Tech Holdings
CLWT
$11.8M
– –
-2,741
Closed -$2K
PRHI
3867
Presurance Holdings
PRHI
$17.2M
– –
-33
Closed -$2K
COE
3868
51Talk Online Education Group
COE
$117M
– –
-225
Closed -$19K
VISN
3869
Vistance Networks Inc
VISN
$2.52B
– –
-434
Closed -$13K
COMT icon
3870
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
$1.18B
– –
-297
Closed -$10K
CPER icon
3871
United States Copper Index Fund
CPER
$772M
– –
-96
Closed -$1K
CPIX icon
3872
Cumberland Pharmaceuticals
CPIX
$117M
$0 ﹤0.01%
38
-1,276
-97% -$6.66K
CPSH icon
3873
CPS Technologies
CPSH
$86.1M
– –
-294
Closed –
CRBN icon
3874
iShares Low Carbon Optimized MSCI ACWI ETF
CRBN
$1.18B
$0 ﹤0.01%
+4
New +$385
CREG
3875
DELISTED
Smart Powerr
CREG
– –
-1
Closed -$1K
153 154
155
156 157

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.